default author photo

Adora Rooyakkers

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

64

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double blinded phase 3 trial

Number of pages: 34 Posted: 01 Oct 2025
Adora Rooyakkers, Lingyun Ye, Pedro E. Cahn, Guillermo M. Ruiz-Palacios, Aamer Ikram, Fernando Lanas, Sergio Munoz, Omar Sued, Dmitry Lioznov, Vitalina Dzutseva, Ghazala Parveen, Tatyana Zubkova, Jing-Xin Li, Joanne Marie Langley, Ruijie Wang, Luis Barreto, Jin-Bo Gou, Tao Zhu, Carrie A. Whittle and Scott A. Halperin
affiliation not provided to SSRN, Dalhousie University, Fundación Huésped, affiliation not provided to SSRN, National Institutes of Health, Chak Shahzad, Universidad de la Frontera, Independent, affiliation not provided to SSRN, Ministry of Health of the Russian Federation, Novosibirsk State University, affiliation not provided to SSRN, Ministry of Health of the Russian Federation, Nanjing Medical University, Dalhousie University, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Dalhousie University and Dalhousie University
Downloads 64 (924,743)

Abstract:

Loading...

Efficacy, safety, immunogenicity, adenovirus type 5, vaccine, SARS-CoV-2, phase 3, booster